Patient-level costs of major cardiovascular conditions: a review of the international literature

References

• World Health Organization [webpage on the Internet]Cardiovascular Diseases (CVD) Fact Sheet2013 Available from: http://www.who.int/mediacentre/factsheets/fs317/en/index.htmlAccessed April 20, 2013
   Google Scholar
• LaslettLJAlagonaPJrClarkBA3rdThe worldwide environment of cardiovascular disease: prevalence, diagnosis, therapy, and policy issues: a report from the American College of CardiologyJ Am Coll Cardiol20126025 supplS1S4923257320
   PubMed Web of Science ®Google Scholar
• NicholsMTownsendNScarboroughPRaynerMCardiovascular disease in Europe: epidemiological updateEur Heart J201334393028303424014390
   PubMed Web of Science ®Google Scholar
• European Heart Network [webpage on the Internet]European Cardiovascular Disease Statistics2012 Available from: http://www.ehnheart.org/cvd-statistics.htmlAccessed October 14, 2013
   Google Scholar
• DemaerschalkBMHwangHMLeungGUS cost burden of ischemic stroke: a systematic literature reviewAm J Manag Care201016752553320645668
   PubMed Web of Science ®Google Scholar
• Luengo-FernandezRGrayAMRothwellPMCosts of stroke using patient-level data: a critical review of the literatureStroke2009402e18e2319109540
   PubMed Web of Science ®Google Scholar
• United States Bureau of Labor Statistics [webpage on the Internet]Consumer Price Index. Current Series2013 Available from: http://www.bls.gov/cpi/data.htmAccessed October 23, 2013
   Google Scholar
• World Bank [webpage on the Internet]PPP conversion factor, GDP (LCU per international $)2015 Available from: http://data.world-bank.org/indicator/PA.NUS.PPPAccessed February 16, 2015
   Google Scholar
• ChapmanRHLiuLZGirasePGStrakaRJDetermining initial and follow-up costs of cardiovascular events in a US managed care populationBMC Cardiovasc Disord2011111121410963
   PubMed Web of Science ®Google Scholar
• StrakaRJLiuLZGirasePSDeLorenzoAChapmanRHIncremental cardiovascular costs and resource use associated with diabetes: an assessment of 29,863 patients in the US managed-care settingCardiovasc Diabetol200985319781099
   PubMed Web of Science ®Google Scholar
• HolstensonERingborgALindgrenPPredictors of costs related to cardiovascular disease among patients with atrial fibrillation in five European countriesEuropace2011131233020823043
   PubMed Web of Science ®Google Scholar
• MoleerergpoomWKanjanavanitRJintapakornWSritaraPCosts of payment in Thai acute coronary syndrome patientsJ Med Assoc Thai200790suppl 1213118431883
   PubMedGoogle Scholar
• O’SullivanAKRubinJNyamboseJKuznikACohenDJThompsonDCost estimation of cardiovascular disease events in the USPharmacoeconomics201129869370421585226
   PubMed Web of Science ®Google Scholar
• MillerCDHwangWCaseDStress CMR imaging observation unit in the emergency department reduces 1-year medical care costs in patients with acute chest pain: a randomized study for comparison with inpatient careJACC Cardiovasc Imaging20114886287021835378
   PubMed Web of Science ®Google Scholar
• WieserSRuthemannIDe BoniSCost of acute coronary syndrome in Switzerland in 2008Swiss Med Wkly2012142w1365522915246
   PubMed Web of Science ®Google Scholar
• NaccarelliGVJohnstonSSLinJPatelPPSchulmanKLCost burden of cardiovascular hospitalization and mortality in ATHENA-like patients with atrial fibrillation/atrial flutter in the United StatesClin Cardiol201033527027920513065
   PubMed Web of Science ®Google Scholar
• TimbieJWNormandSLA comparison of methods for combining quality and efficiency performance measures: profiling the value of hospital care following acute myocardial infarctionStat Med20082791351137017922491
   PubMed Web of Science ®Google Scholar
• SchreyoggJStargardtTThe trade-off between costs and outcomes: the case of acute myocardial infarctionHealth Serv Res2010456 pt 11585160120819109
   PubMed Web of Science ®Google Scholar
• HasanOOravEJHicksLSInsurance status and hospital care for myocardial infarction, stroke, and pneumoniaJ Hosp Med20105845245920540165
   PubMed Web of Science ®Google Scholar
• KruseGBPolskyDStuartEAWernerRMThe impact of hospital pay-for-performance on hospital and Medicare costsHealth Serv Res20124762118213623088391
   PubMed Web of Science ®Google Scholar
• TiemannOVariations in hospitalisation costs for acute myocardial infarction – a comparison across EuropeHealth Econ2008171 supplS33S4518186036
   PubMed Web of Science ®Google Scholar
• HakkinenUChiarelloPCotsFPeltolaMRattoHEuroDRG GroupPatient classification and hospital costs of care for acute myocardial infarction in nine European countriesHealth Econ201221suppl 2192922815109
   PubMed Web of Science ®Google Scholar
• HakkinenUHartikainenJJuntunenMMalmivaaraAPeltolaMTieralaIAnalysing current trends in care of acute myocardial infarction using PERFECT dataAnn Med201143suppl 1S14S2121639713
   PubMed Web of Science ®Google Scholar
• GregoriDDesideriABigiRProper modeling strategies selection for the assessment of post-infarction costsInt J Cardiol20081291535817707925
   PubMed Web of Science ®Google Scholar
• Lopez-ValcarcelBGPinillaJThe impact of medical technology on health: a longitudinal analysis of ischemic heart diseaseValue Health2008111889618237363
   PubMed Web of Science ®Google Scholar
• RingborgAYinDDMartinellMStalhammarJLindgrenPThe impact of acute myocardial infarction and stroke on health care costs in patients with type 2 diabetes in SwedenEur J Cardiovasc Prev Rehabil200916557658219491686
   PubMedGoogle Scholar
• WilhelmsenLWelinLOdenABjornbergASaving lives, money and resources: drug and CABG/PCI use after myocardial infarction in a Swedish record-linkage studyEur J Health Econ201011217718419495819
   PubMed Web of Science ®Google Scholar
• AdemiZLiewDHollingsworthBThe economic implications of treating atherothrombotic disease in Australia, from the government perspectiveClin Ther2010321119132 discussion 106–11720171418
   PubMed Web of Science ®Google Scholar
• United Nations Statistical Divison [webpage on the Internet]European Regions2013 Available from: http://unstats.un.org/unsd/default.htmAccessed April 27, 2015
   Google Scholar
• BognerHRMillerSDde VriesHFChhatreSJayadevappaRAssessment of cost and health resource utilization for elderly patients with heart failure and diabetes mellitusJ Card Fail201016645446020610226
   PubMed Web of Science ®Google Scholar
• ChhatreSWeinerMGJayadevappaRJohnsonJCIncremental burden of congestive heart failure among elderly with Alzheimer’sAging Ment Health200913462863419629789
   PubMed Web of Science ®Google Scholar
• LiaoLAnstromKJGottdienerJSLong-term costs and resource use in elderly participants with congestive heart failure in the Cardiovascular Health StudyAm Heart J2007153224525217239685
   PubMed Web of Science ®Google Scholar
• DunlaySMShahNDShiQLifetime costs of medical care after heart failure diagnosisCirc Cardiovasc Qual Outcomes201141687521139091
   PubMed Web of Science ®Google Scholar
• TrogdonJGFinkelsteinEANwaiseIATangkaFKOrensteinDThe economic burden of chronic cardiovascular disease for major insurersHealth Promot Pract20078323424217606951
   PubMedGoogle Scholar
• EspositoDBagchiADVerdierJMBencioDSKimMSMedicaid beneficiaries with congestive heart failure: association of medication adherence with healthcare use and costsAm J Manag Care200915743744519589011
   PubMed Web of Science ®Google Scholar
• UnroeKTGreinerMAHernandezAFResource use in the last 6 months of life among Medicare beneficiaries with heart failure, 2000–2007Arch Intern Med2011171319620320937916
   PubMedGoogle Scholar
• AllenLAAnstromKJHortonJRShawLKEisensteinELFelkerGMRelationship between anemia and health care costs in heart failureJ Card Fail2009151084384919944360
   PubMedGoogle Scholar
• ChenLMJhaAKGutermanSRidgwayABOravEJEpsteinAMHospital cost of care, quality of care, and readmission rates: penny wise and pound foolish?Arch Intern Med2010170434034620177036
   PubMedGoogle Scholar
• ChenSIDharmarajanKKimNProcedure intensity and the cost of careCirc Cardiovasc Qual Outcomes20125330831322576844
   PubMed Web of Science ®Google Scholar
• ChiongJRKimSLinJChristianRDastaJFEvaluation of costs associated with tolvaptan-mediated length-of-stay reduction among heart failure patients with hyponatremia in the US, based on the EVEREST trialJ Med Econ201215227628422111754
   PubMedGoogle Scholar
• GregoryDOrdwayLJMcGillivrayMKonstamMADenofrioDA cost-saving strategy for inpatient management of advanced decompensated heart failure patients: the Cardiomyopathy UnitJ Card Fail200915542843419477403
   PubMed Web of Science ®Google Scholar
• TitlerMGJensenGADochtermanJMCost of hospital care for older adults with heart failure: medical, pharmaceutical, and nursing costsHealth Serv Res200843263565518370971
   PubMed Web of Science ®Google Scholar
• WangGZhangZAyalaCWallHKFangJCosts of heart failure-related hospitalizations in patients aged 18 to 64 yearsAm J Manag Care2010161076977620964473
   PubMed Web of Science ®Google Scholar
• JoyntKEOravEJJhaAKThe association between hospital volume and processes, outcomes, and costs of care for congestive heart failureAnn Intern Med201115429410221242366
   PubMed Web of Science ®Google Scholar
• ShoemakerWVariability in service line costs for heart failure and shockHealthc Financ Manage201266616622734334
   PubMedGoogle Scholar
• PatelUDGreinerMAFonarowGCPhatakHHernandezAFCurtisLHAssociations between worsening renal function and 30-day outcomes among Medicare beneficiaries hospitalized with heart failureAm Heart J20101601132138.e13120598983
   PubMed Web of Science ®Google Scholar
• GreinerMAHammillBGFonarowGCPredicting costs among Medicare beneficiaries with heart failureAm J Cardiol2012109570571122154317
   PubMed Web of Science ®Google Scholar
• WhellanDJGreinerMASchulmanKACurtisLHCosts of inpatient care among Medicare beneficiaries with heart failure, 2001 to 2004Circ Cardiovasc Qual Outcomes201031334020123669
   PubMed Web of Science ®Google Scholar
• KociolRDGreinerMAHammillBGLong-term outcomes of Medicare beneficiaries with worsening renal function during hospitalization for heart failureAm J Cardiol2010105121786179320538131
   PubMed Web of Science ®Google Scholar
• PattersonMEGrantWCGlickmanSWResource use and costs of treatment with anticoagulation and antiplatelet agents: results of the WATCH trial economic evaluationJ Card Fail2009151081982719944357
   PubMedGoogle Scholar
• ReedSDLiYDunlapMEIn-hospital resource use and medical costs in the last year of life by mode of death (from the HF-ACTION randomized controlled trial)Am J Cardiol201211081150115522762718
   PubMed Web of Science ®Google Scholar
• ChanPSSotoGJonesPGPatient health status and costs in heart failure: insights from the eplerenone post-acute myocardial infarction heart failure efficacy and survival study (EPHESUS)Circulation2009119339840719139382
   PubMed Web of Science ®Google Scholar
• CaporaleJEElgartJPfirterGHospitalization costs for heart failure in people with type 2 diabetes: cost-effectiveness of its prevention measured by a simulated preventive treatmentValue Health2011145 suppl 1S20S2321839892
   PubMed Web of Science ®Google Scholar
• KaulPMcAlisterFAEzekowitzJAResource use in the last 6 months of life among patients with heart failure in CanadaArch Intern Med2011171321121720937918
   PubMedGoogle Scholar
• DilokthornsakulPChaiyakunaprukNNimpitakpongPJeanpeerapongNSruamsiriRThe effects of medication supply on hospitalizations and health-care costs in patients with chronic heart failureValue Health2012151 supplS9S1422265074
   PubMed Web of Science ®Google Scholar
• EllisCStroke in young adultsDisabil Health J20103322222421122787
   PubMed Web of Science ®Google Scholar
• EllisCSimpsonANBonilhaHMauldinPDSimpsonKNThe one-year attributable cost of poststroke aphasiaStroke20124351429143122343643
   PubMed Web of Science ®Google Scholar
• Engel-NitzNMSanderSDHarleyCReyGGShahHCosts and outcomes of noncardioembolic ischemic stroke in a managed care populationVasc Health Risk Manag2010690591320957133
   PubMedGoogle Scholar
• KindAJSmithMALiouJIPandhiNFrytakJRFinchMDThe price of bouncing back: one-year mortality and payments for acute stroke patients with 30-day bounce-backsJ Am Geriatr Soc2008566999100518422948
   PubMed Web of Science ®Google Scholar
• LeeWCChristensenMCJoshiAVPashosCLLong-term cost of stroke subtypes among Medicare beneficiariesCerebrovasc Dis2007231576517065788
   PubMed Web of Science ®Google Scholar
• MahoneyEMWangKCohenDJOne-year costs in patients with a history of or at risk for atherothrombosis in the United StatesCirc Cardiovasc Qual Outcomes200811384520031786
   PubMed Web of Science ®Google Scholar
• RobertsCSGorelickPBYeXHarleyCGoldbergGAAdditional stroke-related and non-stroke-related cardiovascular costs and hospitalizations in managed-care patients after ischemic strokeStroke20094041425143219246698
   PubMed Web of Science ®Google Scholar
• ZorowitzRDChenETongKBLaouriMCosts and rehabilitation use of stroke survivors: a retrospective study of Medicare beneficiariesTop Stroke Rehabil200916530932019903649
   PubMed Web of Science ®Google Scholar
• BruggenjurgenBRossnagelKRollSThe impact of atrial fibrillation on the cost of stroke: the berlin acute stroke studyValue Health200710213714317391422
   PubMed Web of Science ®Google Scholar
• ChristensenMCMunroVIschemic stroke and intracerebral hemorrhage: the latest evidence on mortality, readmissions and hospital costs from ScotlandNeuroepidemiology200830423924618446043
   PubMed Web of Science ®Google Scholar
• GhatnekarOGladerELThe effect of atrial fibrillation on stroke-related inpatient costs in Sweden: a 3-year analysis of registry incidence data from 2001Value Health200811586286818489491
   PubMed Web of Science ®Google Scholar
• Luengo-FernandezRGrayAMRothwellPMOxford Vascular StudyA population-based study of hospital care costs during 5 years after transient ischemic attack and strokeStroke201243123343335123160884
   PubMed Web of Science ®Google Scholar
• MahlerMPZugerKKasparKA cost analysis of the first year after stroke – early triage and inpatient rehabilitation may reduce long term costsSwiss Med Wkly200813831–3245946518690559
   PubMed Web of Science ®Google Scholar
• McGuireAJRaikouMWhittleIChristensenMCLong-term mortality, morbidity and hospital care following intracerebral hemorrhage: an 11-year cohort studyCerebrovasc Dis2007232–322122817143007
   PubMed Web of Science ®Google Scholar
• MeretojaAKasteMRoineRODirect costs of patients with stroke can be continuously monitored on a national level: performance, effectiveness, and Costs of Treatment episodes in Stroke (PERFECT Stroke) Database in FinlandStroke20114272007201221527757
   PubMed Web of Science ®Google Scholar
• ThijsVDewildeSPutmanKPinceHCost of hospitalization for cerebrovascular disorders in BelgiumActa Neurol Belg2011111210411021748928
   PubMed Web of Science ®Google Scholar
• WinterYWolframCSchaegMEvaluation of costs and outcome in cardioembolic stroke or TIAJ Neurol2009256695496319252783
   PubMed Web of Science ®Google Scholar
• GioldasisGTalelliPChroniEDaouliJPapapetropoulosTEllulJIn-hospital direct cost of acute ischemic and hemorrhagic stroke in GreeceActa Neurol Scand2008118426827418384454
   PubMed Web of Science ®Google Scholar
• MaYLiuYFuHMEvaluation of admission characteristics, hospital length of stay and costs for cerebral infarction in a medium-sized city in ChinaEur J Neurol201017101270127620402751
   PubMed Web of Science ®Google Scholar
• SunYTohMPImpact of diabetes mellitus (DM) on the health-care utilization and clinical outcomes of patients with stroke in SingaporeValue Health200912suppl 3S101S10520586969
   PubMed Web of Science ®Google Scholar
• WangIKMuoCHChangYCRisks, subtypes, and hospitalization costs of stroke among patients with systemic lupus erythematosus: a retrospective cohort study in TaiwanJ Rheumatol20123981611161822753653
   PubMed Web of Science ®Google Scholar
• WeiJWHeeleyELJanSVariations and determinants of hospital costs for acute stroke in ChinaPLoS One201059e1304120927384
   PubMed Web of Science ®Google Scholar
• ChristensenMCPreviglianoICapparelliFJLermanDLeeWCWainszteinNAAcute treatment costs of intracerebral hemorrhage and ischemic stroke in ArgentinaActa Neurol Scand2009119424625318771525
   PubMed Web of Science ®Google Scholar
• ChristensenMCValienteRSampaio SilvaGAcute treatment costs of stroke in BrazilNeuroepidemiology200932214214919088487
   PubMed Web of Science ®Google Scholar
• MittmannNSeungSJHillMDImpact of disability status on ischemic stroke costs in Canada in the first yearCan J Neurol Sci201239679380023041400
   PubMed Web of Science ®Google Scholar
• AuerbachADHiltonJFMaselliJPekowPSRothbergMBLindenauerPKCase volume, quality of care, and care efficiency in coronary artery bypass surgeryArch Intern Med2010170141202120820660837
   PubMedGoogle Scholar
• BirkmeyerJDGustCDimickJBBirkmeyerNJSkinnerJSHospital quality and the cost of inpatient surgery in the United StatesAnn Surg201225511522156928
   PubMed Web of Science ®Google Scholar
• ChastekBRiedelAAWygantGHauchOEvaluation of hospitalization and follow-up care costs among patients hospitalized with ACS treated with a stent and clopidogrelCurr Med Res Opin200925122845285219831706
   PubMed Web of Science ®Google Scholar
• ChenJCKaulPLevyJHMyocardial infarction following coronary artery bypass graft surgery increases healthcare resource utilizationCrit Care Med20073551296130117414091
   PubMed Web of Science ®Google Scholar
• EisensteinELSunJLAnstromKJDeLongERSzczechLAMarkDBAssessing the economic attractiveness of coronary artery revascularization in chronic kidney disease patientsJ Med Syst200933428729719697695
   PubMed Web of Science ®Google Scholar
• EisensteinELWijnsWFajadetJLong-term clinical and economic analysis of the Endeavor drug-eluting stent versus the Driver bare-metal stent: 4-year results from the ENDEAVOR II trial (Randomized Controlled Trial to Evaluate the Safety and Efficacy of the Medtronic AVE ABT-578 Eluting Driver Coronary Stent in De Novo Native Coronary Artery Lesions)JACC Cardiovasc Interv20092121178118720129543
   PubMed Web of Science ®Google Scholar
• HlatkyMABoothroydDBMelsopKAEconomic outcomes of treatment strategies for type 2 diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trialCirculation2009120252550255819920002
   PubMed Web of Science ®Google Scholar
• JohnstonSSBellKGdovinJJingYGrahamJCoronary artery bypass graft surgery in acute coronary syndrome: incidence, cost impact, and acute clopidogrel interruptionHosp Pract (1995)2012401152322406879
   PubMedGoogle Scholar
• KesslerDPKrochEHlatkyMAThe effect of bivalirudin on costs and outcomes of treatment of ST-segment elevation myocardial infarctionAm Heart J20111623494500.e49221884866
   PubMed Web of Science ®Google Scholar
• LaParDJBhamidipatiCMReeceTBClevelandJCKronILAilawadiGIs off-pump coronary artery bypass grafting superior to conventional bypass in octogenarians?J Thorac Cardiovasc Surg20111411819021051050
   PubMed Web of Science ®Google Scholar
• LaParDJStukenborgGJGuyerRAPrimary payer status is associated with mortality and resource utilization for coronary artery bypass graftingCirculation201212611 suppl 1S132S13922965973
   PubMed Web of Science ®Google Scholar
• LindseyJBCohenDJStolkerJMThe impact of bivalirudin on percutaneous coronary intervention-related bleedingEuroIntervention20106220621320562070
   PubMed Web of Science ®Google Scholar
• MarkDBKnightJDVelazquezEJQuality of life and economic outcomes with surgical ventricular reconstruction in ischemic heart failure: results from the Surgical Treatment for Ischemic Heart Failure trialAm Heart J20091575837844844.e83183319376309
   PubMed Web of Science ®Google Scholar
• OlchanskiNSlawskyKAPlentSKadoCCyrPLEconomic impact of switching to bivalirudin for a primary percutaneous coronary intervention in a US hospitalHosp Pract (1995)201038413814621068538
   PubMedGoogle Scholar
• PhilipsonTJMozaffariEMacleanJRPharmacy cost sharing, antiplatelet therapy utilization, and health outcomes for patients with acute coronary syndromeAm J Manag Care201016429029720394466
   PubMed Web of Science ®Google Scholar
• PintoDSStoneGWShiCEconomic evaluation of bivalirudin with or without glycoprotein IIb/IIIa inhibition versus heparin with routine glycoprotein IIb/IIIa inhibition for early invasive management of acute coronary syndromesJ Am Coll Cardiol200852221758176819022155
   PubMed Web of Science ®Google Scholar
• PostonRSTranRCollinsMComparison of economic and patient outcomes with minimally invasive versus traditional off-pump coronary artery bypass grafting techniquesAnn Surg2008248463864618936577
   PubMed Web of Science ®Google Scholar
• RihalCSRyanJLSinghMClinical and economic outcomes after introduction of drug-eluting stentsAm J Manag Care201016858058720712391
   PubMed Web of Science ®Google Scholar
• RyanJLinde-ZwirbleWEngelhartLCooperLCohenDJTemporal changes in coronary revascularization procedures, outcomes, and costs in the bare-metal stent and drug-eluting stent eras: results from the US Medicare programCirculation2009119795296119204307
   PubMed Web of Science ®Google Scholar
• SalehSSRaczMHannanEThe effect of preoperative and hospital characteristics on costs for coronary artery bypass graftAnn Surg2009249233534119212191
   PubMed Web of Science ®Google Scholar
• SpeirAMKasirajanVBarnettSDFonnerEJrAdditive costs of postoperative complications for isolated coronary artery bypass grafting patients in VirginiaAnn Thorac Surg20098814045 discussion 45–4619559186
   PubMed Web of Science ®Google Scholar
• VogelTRDombrovskiyVYLowrySFIn-hospital delay of elective surgery for high volume procedures: the impact on infectious complicationsJ Am Coll Surg2010211678479020980170
   PubMed Web of Science ®Google Scholar
• BakhaiAFerrieresJIniguezAClinical outcomes, resource use, and costs at 1 year in patients with acute coronary syndrome undergoing PCI: results from the multinational APTOR registryJ Interv Cardiol2012251192722150757
   PubMed Web of Science ®Google Scholar
• BramkampMRadovanovicDErnePSzucsTDDeterminants of costs and the length of stay in acute coronary syndromes: a real life analysis of more than 10,000 patientsCardiovasc Drugs Ther200721538939817805954
   PubMed Web of Science ®Google Scholar
• DendalePHansenDBergerJLamotteMLong-term cost-benefit ratio of cardiac rehabilitation after percutaneous coronary interventionActa Cardiol200863445145618795582
   PubMed Web of Science ®Google Scholar
• EpsteinDMSculpherMJClaytonTCCosts of an early intervention versus a conservative strategy in acute coronary syndromeInt J Cardiol2008127224024617707103
   PubMed Web of Science ®Google Scholar
• FriedelHDelgesAClouthJTrautvetterDTExpenditures of the German statutory health insurance system for patients suffering from acute coronary syndrome and treated with percutaneous coronary interventionEur J Health Econ201011544945519774404
   PubMed Web of Science ®Google Scholar
• GaughanJKobelCLinhartCEuroDRG GroupWhy do patients having coronary artery bypass grafts have different costs or length of stay? An analysis across 10 European countriesHealth Econ201221suppl 2778822815114
   PubMed Web of Science ®Google Scholar
• KastaniotiCCosts, clinical outcomes, and health-related quality of life of off-pump vs. on-pump coronary bypass surgeryEur J Cardiovasc Nurs200761545916750426
   PubMedGoogle Scholar
• OdellALandeliusPAstrom-OlssonKGripLThe impact of general usage of stents on short- and long-term health care costs following percutaneous coronary interventionCardiology20081092859217664872
   PubMed Web of Science ®Google Scholar
• VaraniEBalducelliMVecchiGAquilinaMMarestaAOne-year clinical results and total costs of drug-eluting stents implantation in multivessel coronary artery diseaseJ Cardiovasc Med (Hagerstown)20078859660117667030
   PubMed Web of Science ®Google Scholar
• VaraniEBalducelliMVecchiGAquilinaMMarestaAComparison of multiple drug-eluting stent percutaneous coronary intervention and surgical revascularization in patients with multivessel coronary artery disease: one-year clinical results and total treatment costsJ Invasive Cardiol2007191146947517986722
   PubMedGoogle Scholar
• ForouzanniaSKAbdollahiMHMirhosseiniSJClinical outcome and cost in patients with off-pump vs. on-pump coronary artery bypass surgeryActa Med Iran201149741441921960071
   PubMedGoogle Scholar
• HuSLiQGaoPSimultaneous hybrid revascularization versus off-pump coronary artery bypass for multivessel coronary artery diseaseAnn Thorac Surg201191243243821256284
   PubMed Web of Science ®Google Scholar
• HuSZhengZYuanXIncreasing long-term major vascular events and resource consumption in patients receiving off-pump coronary artery bypass: a single-center prospective observational studyCirculation2010121161800180820385931
   PubMed Web of Science ®Google Scholar
• NoguchiHShimizutaniSMasudaYRegional variations in medical expenditure and hospitalization days for heart attack patients in Japan: evidence from the Tokai Acute Myocardial Study (TAMIS)Int J Health Care Finance Econ20088212314418204898
   PubMedGoogle Scholar
• SakakuraKAkoJWadaHKuboNMomomuraSComparison of the resource utilization between simultaneous strategy and staged strategy to treat two-vessel coronary artery disease by percutaneous coronary interventionJ Invasive Cardiol2011231145445922045077
   PubMed Web of Science ®Google Scholar
• ShimizuTOhnoTAndoJMid-term results and costs of coronary artery bypass vs drug-eluting stents for unprotected left main coronary artery diseaseCirc J201074344945520075560
   PubMed Web of Science ®Google Scholar
• ZhaoFHLuSZLiHClinical outcomes and cost-utility after sirolimus-eluting versus bare metal stent implantationChin Med J (Engl)2010123202797280221034585
   PubMed Web of Science ®Google Scholar
• GirardiPBHuebWNogueiraCRComparative costs between myocardial revascularization with or without extracorporeal circulationArq Bras Cardiol200891634034619142359
   PubMed Web of Science ®Google Scholar
• HaddadNBittarEde MarchiAFHospital costs of coronary artery bypass grafting on elective coronary patientsArq Bras Cardiol200788441842317546271
   PubMed Web of Science ®Google Scholar
• RodriguezAEMareeATarragonaSPercutaneous coronary intervention with oral sirolimus and bare metal stents has comparable safety and efficacy to treatment with drug eluting stents, but with significant cost saving: long-term follow-up results from the randomised, controlled ORAR III (Oral Rapamycin in ARgentina) studyEuroIntervention20095225526420449934
   PubMed Web of Science ®Google Scholar
• ArnoldSVMorrowDALeiYEconomic impact of angina after an acute coronary syndrome: insights from the MERLIN-TIMI 36 trialCirc Cardiovasc Qual Outcomes20092434435320031860
   PubMed Web of Science ®Google Scholar
• CohenDJLavelleTAVan HoutBEconomic outcomes of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with left main or three-vessel coronary artery disease: one-year results from the SYNTAX trialCatheter Cardiovasc Interv201279219820921542113
   PubMed Web of Science ®Google Scholar
• RinfretSKennedyWALachaineJEconomic impact of same-day home discharge after uncomplicated transradial percutaneous coronary intervention and bolus-only abciximab regimenJACC Cardiovasc Interv20103101011101920965458
   PubMed Web of Science ®Google Scholar
• PayneKAHuybrechtsKFCaroJJCraig GreenTJKlittichWSLong term cost-of-illness in stroke: an international reviewPharmacoeconomics2002201281382512236803
   PubMed Web of Science ®Google Scholar
• ReynoldsMWFrameDScheyeRA systematic review of the economic burden of chronic anginaAm J Manag Care20041011 supplS347S35715603244
   PubMed Web of Science ®Google Scholar